Page last updated: 2024-10-25

debrisoquin and Back Pain

debrisoquin has been researched along with Back Pain in 2 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Back Pain: Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skeith, KJ1
Hussain, MS1
Coutts, RT1
Ramos-Remus, C1
Avina-Zubieta, JA1
Russell, AS1
Omenn, GS1

Reviews

1 review available for debrisoquin and Back Pain

ArticleYear
Ethnic differences in reactions to drugs and xenobiotics. Susceptibility to occupational and environmental exposures to chemicals.
    Progress in clinical and biological research, 1986, Volume: 214

    Topics: Acetylation; alpha 1-Antitrypsin; Anemia, Hemolytic; Aryl Hydrocarbon Hydroxylases; Asian People; Ba

1986

Trials

1 trial available for debrisoquin and Back Pain

ArticleYear
Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia.
    Clinical rheumatology, 1997, Volume: 16, Issue:3

    Topics: Adult; Analgesics; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Age

1997